Many blue chip and former large-caps are down huge amounts over the last year as well & the bear market has been especially tough for small/micro cap biotech stocks.
I have also written about stocks on the Motley Fool & other sites such as Sequenom (SQNM), Isis Pharma (ISIS), Alnylam (ALNY), Xenoport (XNPT), Vivus (VVUS), VisICU (EICU), North Pitt (NPSI), Savient Pharma (SVNT), Allos Therapeutics (ALTH) that have done much better than the examples you list. Sequenom alone is almost four-fold from last year.
-
Many blue chip and former large-caps are down huge amounts over the last year as well & the bear market has been especially tough for small/micro cap biotech stocks.
Jul 06 14:29 pm
|Rating:
0
0
All Comments by Mike Havrilla »A New Strategy for EXACT Sciences [View article]
I have also written about stocks on the Motley Fool & other sites such as Sequenom (SQNM), Isis Pharma (ISIS), Alnylam (ALNY), Xenoport (XNPT), Vivus (VVUS), VisICU (EICU), North Pitt (NPSI), Savient Pharma (SVNT), Allos Therapeutics (ALTH) that have done much better than the examples you list. Sequenom alone is almost four-fold from last year.